Event Overview

eyeforpharma's 6th Annual Sales Force Effectiveness Summit USA

Through months of in-depth research eyeforpharma have developed an innovative and information rich program based on what the industry wants. This ensures you get the most relevant, focused information you need and guarantees you maximize your time out of the office. These two intensive days address the most important aspects of SFE in North America.

Following on from 5 years of highly successful Global Pharmaceutical Sales conferences eyeforpharma's latest offering in this field guarantees you the insights, strategies and contacts you need to drive sales growth and measure ROI in complex and changing environment.

New speakers have been confirmed in the last week, making this one of the largest gathering of SFE experts in North America . The latest speakers to come on board are:

• Ed Bryden, Senior Director Marketing Analytics, Abbott will help you identify the best data source and will discuss best practice for producing a reliable data program
• Ken Liss, National Sales Director, Bayer HealthCare will be taking an in depth look in to the near future to analyze the latest trends, so you can plan and impose strategies for long term success
• Jeremy Stamer, Director Business Analytics, Amylin will show you how to extract maximum value from Patient-Level data to optimize rep face-time
• Duke Garvin, Former Director of Sales Force Effectiveness , Pfizer will present on how to build an Incentive Compensation System that is compliant and hits the targets
• Don Hribek, Vice President Strategic Accounts , EMD Serono will explore which new selling models, including Key Account Management will give you the competitive advantage
• Mike Pucci, VP, External Advocacy, GlaxoSmithKline will discuss the value of medicine and the value of the sales representative and will analyze the current state of trust between consumers and the Pharma industry

KEY POINTS TO BE ADDRESSED AT THE SUMMIT:

• Training and Development:
• Proven strategies that will accelerate the effectiveness of First Line managers
• Fresh ways to examine the role of the rep and to decrease turnover
• How to Use Analytics in Launch Phase and Beyond:
• Explore effective techniques that enable you to decipher and manage data and learn how these will allow your business to grow
• Maximise Co-Promotion:
• Tips on the right paths to success with this strategy
• Get Better Physician Access:
• Discover who you should target to get the most out of your reps time and analyze the best ways to maintain and grow access to physicians
• New selling models:
• Which will give you the competitive advantage?

• Learn how the right metrics can enhance program effectiveness

• Proven strategies to enable you to measure productivity that will provide valuable feedback on your investment

World Class Speakers for 2008 already confirmed from:
Company	Speaker
	Michael Castagna, Director Marketing
	Mark Stevens, Director, Strategic Businese Planning
	Elizabeth Sozanski, Senior Director of Marketing Strategy
	Christopher Leidli, District Sales Manager
	Irwin Darack, Director, Sales Excellence
	Julia Brodsky, Director, Business Analytics

I have briefly outlined below the various initiatives we have undertook in order to make the event a success for you:


You said: "Too many service providers and consultants are delivering blatant sales pitches"
What we're doing this year: We have limited the number of service providers and consultants who will present and deliver workshops this year. The number of vendor presentations has been cut dramatically. All presentations have been given in advance to ensure they provide value. They have been scored and reviewed by an independent panel of industry executives, and only those which score highly have been allowed.

You said: "Not enough independent, focused discussion groups"
What we're doing for next year: We are running small discussion groups on particular topics that will be moderated by independent executives, with a limited number of participants per group.

You said: "Presentations lacked substance"
What we're doing for next year: We have implemented a much stricter system for the selection and submission of presentations. As mentioned above, there is a review board of senior executives who have provided feedback on all presentations prior to the event. We are redoubling our efforts to extract information from pharmaceutical companies that is of direct value.

You said: "There was nothing new"
What we're doing for next year: SFE is now a mature subject. Rather than just concentrating on SFE in general, we'll focus on uncovering new topics, as there is real innovation in many areas of SFE. The format of the event will be redesigned to focus on specific topics rather than a general program.

If you would like to partcipate in the event either as a speaker, sponsor or delegate please contact Kate Eversole on +44 (0) 207 375 7594 US TOLL FREE +1 800 814 3459 ext 296 email keversole@eyeforpharma.com